| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
12 companies
Viking Global Investors LP is a 10% Owner at Adaptive Biotechnologies Corp with holdings across 12 companies. Recent SEC Form 4 filings include 10 buys and 4 sells.
Estimated insider holdings value: $2413.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | ADPT Adaptive Biotechnologies Corp | 10% Owner | Sell | 1,000,000 | $55.65 | $55,650,000.00 | -3.2% | |
| Dec 1, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | 10% Owner | Sell | 500,000 | $50.50 | $25,250,000.00 | -11.3% | |
| Nov 11, 2020 | ADPT Adaptive Biotechnologies Corp | 10% Owner | Sell | 2,500,000 | $49.52 | $123,787,500.00 | -7.5% | |
| Apr 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | 10% Owner | Buy | 725,000 | $18.00 | $13,050,000.00 | +19.5% | |
| Jan 28, 2020 | ADPT Adaptive Biotechnologies Corp | 10% Owner | Sell | 4,912,899 | $24.98 | $122,706,039.29 | -12.8% | |
| Jul 1, 2019 | ADPT Adaptive Biotechnologies Corp | 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +17.5% | |
| Jun 27, 2019 | BBIO Bridgebio Pharma, Inc. | 10% Owner | Buy | 4,705,900 | $17.00 | $80,000,300.00 | +21.5% | |
| Feb 8, 2015 | EDIT Editas Medicine, Inc. | 10% Owner | Buy | 2,040,814 | $0.00 | - | +43.6% |